• locale

  United States

• market

  PRIVATE

• industry

  Biotechnology

• website

  venquistx.com

Venquis Therapeutics has developed a small molecule monovalent degrader discovery platform named CIPD, which targets clinically relevant proteins in a mutant-selective fashion for the treatment of oncology and other diseases.